Find Products

Help Us, Help You

We genuinely believe in what we do and want to be the best life sciences supply partner. Any information to help our journey is very welcome. Please take a few minutes to help us improve and make your future experiences better:

FlowDSA-XM™ | New from One Lambda

28 July 2017

FlowDSA-XM | Crossmatch Testing with Selective Detection of Leukocyte Antibodies from Autoantibodies

Crossmatch testing is a mandatory component of the transplant work-up process. Performing crossmatch testing consists of donor lymphocytes against recipient serum. The routine test is used to prevent hyperacute rejection. However, a major limitation of current testing methods is false positives from autoantibodies.

Transplant Workflow

Newly launched by One Lambda, FlowDSA-XM is a Flow Cytometry based crossmatch assay optimised for the detection of leukocyte antibodies.

Combining traditional Flow Cytometry cellular crossmatch testing with the specificity of microbeads technology, the FlowDSA-XM distinguishes leukocyte antibodies from autoantibodies, allowing you to obtain selective detection in the first run.

The workflow involves incubating lymphocytes with human serum. Any IgG on the cell surface is tagged with PE labelled anti-human IgG. FlowDSA-XM Capture Beads bind selectively with the resulting antibody/antigen/PE-anti-IgG complex and the fluorescent intensity is measured to indicate the relative amount of leukocyte antibody present in the serum.


FlowDSA-XM workflow





Back to news

Find Products

We work with a range of suppliers with novel and innovative products sourced from our global partners.

Find Products

Browser Warning

VHBio is not supported on Internet Explorer and will not provide you with the best experience. Please consider switching to a compatible browser such as Microsoft Edge, Google Chrome or Firefox.